CCM
Copernicus Capital Management Portfolio holdings
AUM
$8.26M
This Quarter Return
+7.63%
1 Year Return
+37.91%
3 Year Return
+125.34%
5 Year Return
–
10 Year Return
–
AUM
$138M
AUM Growth
+$138M
(+9.8%)
Cap. Flow
+$5.1M
Cap. Flow
% of AUM
3.7%
Top 10 Holdings %
Top 10 Hldgs %
70.81%
Holding
25
New
5
Increased
12
Reduced
2
Closed
6
Top Buys
| 1 |
CVS Health
CVS
|
$8.73M |
| 2 |
Hologic
HOLX
|
$6.74M |
| 3 |
Integra LifeSciences
IART
|
$4.06M |
| 4 |
Edwards Lifesciences
EW
|
$4.05M |
| 5 |
Henry Schein
HSIC
|
$4M |
Top Sells
| 1 |
Cigna
CI
|
$9.23M |
| 2 |
Biogen
BIIB
|
$9.12M |
| 3 |
Gilead Sciences
GILD
|
$8.78M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.57M |
| 5 |
Molina Healthcare
MOH
|
$5.55M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stryker
SYK
$150B
| $11.9M | 8.6% |
70,209
+18,200
| +35% | +$3.07M |
|
2
Thermo Fisher Scientific
TMO
$186B
| $11.5M | 8.37% |
55,645
+11,645
| +26% | +$2.41M |
|
3
Intuitive Surgical
ISRG
$170B
| $11.5M | 8.36% |
24,073
+485
| +2% | +$232K |
|
4
Illumina
ILMN
$15.8B
| $11.5M | 8.34% |
41,124
+1,646
| +4% | +$460K |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $11.3M | 8.2% |
66,440
+14,196
| +27% | +$2.41M |
|
6
DaVita
DVA
$9.85B
| $9.55M | 6.93% |
137,496
+43,370
| +46% | +$3.01M |
|
|
7
CVS Health
CVS
$94B
| $8.73M | 6.33% |
+135,595
| New | +$8.73M |
|
|
8
Edwards Lifesciences
EW
$47.8B
| $8.44M | 6.13% |
58,000
+27,842
| +92% | +$4.05M |
|
|
9
Hologic
HOLX
$14.9B
| $6.74M | 4.89% |
+169,511
| New | +$6.74M |
|
|
CLVS
10
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.43M | 4.66% |
141,345
+70,253
| +99% | +$3.19M |
|
11
Amicus Therapeutics
FOLD
$2.34B
| $5.82M | 4.23% |
372,798
-2,572
| -0.7% | -$40.2K |
|
12
Heron Therapeutics
HRTX
$207M
| $5.61M | 4.07% |
144,382
+36,382
| +34% | +$1.41M |
|
|
ARRY
13
DELISTED
Array Biopharma Inc
ARRY
| $4.81M | 3.49% |
286,797
+155,379
| +118% | +$2.61M |
|
14
Zoetis
ZTS
$69.3B
| $4.76M | 3.46% |
55,905
+214
| +0.4% | +$18.2K |
|
|
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
| $4.58M | 3.33% |
87,906
+337
| +0.4% | +$17.6K |
|
|
16
Integra LifeSciences
IART
$1.18B
| $4.06M | 2.95% |
+63,000
| New | +$4.06M |
|
|
17
Henry Schein
HSIC
$8.44B
| $4M | 2.9% |
+55,000
| New | +$4M |
|
|
18
Molina Healthcare
MOH
$9.8B
| $3.6M | 2.61% |
36,737
-56,645
| -61% | -$5.55M |
|
19
Humana
HUM
$36.5B
| $2.98M | 2.16% |
+10,000
| New | +$2.98M |
|
|
20
Biogen
BIIB
$19.4B
| – | – |
-33,296
| Closed | -$9.12M |
|
|
21
Cigna
CI
$80.3B
| – | – |
-55,000
| Closed | -$9.23M |
|
|
22
Gilead Sciences
GILD
$140B
| – | – |
-116,506
| Closed | -$8.78M |
|
23
Service Corp International
SCI
$11.1B
| – | – |
-92,796
| Closed | -$3.5M |
|
|
ALXN
24
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-50,000
| Closed | -$5.57M |
|
|
CELG
25
DELISTED
Celgene Corp
CELG
| – | – |
-28,100
| Closed | -$2.51M |
|